询盘
消息
广东南芯医疗科技有限公司

广东南芯医疗科技有限公司

China - Guangzhou
工贸一体
主营产品
临床分析仪器,医疗耗材,鼻咽拭子,病毒快速检测试剂盒,采样管,核酸提取仪,核酸检测试剂/荧光检测试剂盒,粪便/痰样本容器,植绒棉签
产品目录
广东南芯医疗科技有限公司
  • 广东南芯医疗科技有限公司
  • 广东南芯医疗科技有限公司
  • 广东南芯医疗科技有限公司
  • 广东南芯医疗科技有限公司
  • 广东南芯医疗科技有限公司
企业信息
LongseeMed was Founded in 2015, it is an international provider of advanced core technologies, products and data related to "IVD (reagent + instrument),Functional food,Fecal microbiota transplantation,Living biological medicine,Medical care services " founded by a team of returned scholars.LongseeMed based in Guangzhou, China, the company has R&D, Data and Technical service centers in Beijing, Chongqing, Wuhan and Singapore. Nanxin Medical established an independent third-party medical testing laboratory in 2019, and obtained the qualifications of medical institutions and ISO9001 quality management system certification that year, which can carry out clinical biochemical, cellular molecular, and immunological testing projects. At the beginning of 2020, Nanxin Medical Inspection Laboratory obtained the qualification of clinical gene amplification laboratory and was selected as one of the 18 third-party institutions designated by Guangzhou City to conduct COVID-19 nucleic acid testing. Nanxin Medical Inspection Laboratory has a complete infrastructure, with eight standardized negative pressure BSL-2 Plus laboratories, and world-class platform instruments: second-generation sequencing platform (two), mass spectrometry platform (two) , Liquid-phase chip platform, flow cytometry platform and multiple automation equipment, the total amount of laboratory equipment is more than 30 million yuan. At present, Nanxin Medical Inspection Laboratory has carried out intestinal and female reproductive tract microbial testing services, pathogenic microbial metagenomic testing services, vitamin metabolism testing and human immunity assessment and other clinical major health testing services, committed to making micro-ecologies benefit mankind Health; At the same time, Nanxin Laboratories also develops multi-omics scientific research and technical services serving major universities, hospitals, and research institutes. Genomics, transcriptomics, proteomics and metabolomics are jointly combined to promote the latest biomedical industry Scientific research results.
LongseeMed was Founded in 2015, it is an international provider of advanced core technologies, products and data related to "IVD (reagent + instrument),Functional food,Fecal microbiota transplantation,Living biological medicine,Medical care services " founded by a team of returned scholars.LongseeMed based in Guangzhou, China, the company has R&D, Data and Technical service centers in Beijing, Chongqing, Wuhan and Singapore. Nanxin Medical established an independent third-party medical testing laboratory in 2019, and obtained the qualifications of medical institutions and ISO9001 quality management system certification that year, which can carry out clinical biochemical, cellular molecular, and immunological testing projects. At the beginning of 2020, Nanxin Medical Inspection Laboratory obtained the qualification of clinical gene amplification laboratory and was selected as one of the 18 third-party institutions designated by Guangzhou City to conduct COVID-19 nucleic acid testing. Nanxin Medical Inspection Laboratory has a complete infrastructure, with eight standardized negative pressure BSL-2 Plus laboratories, and world-class platform instruments: second-generation sequencing platform (two), mass spectrometry platform (two) , Liquid-phase chip platform, flow cytometry platform and multiple automation equipment, the total amount of laboratory equipment is more than 30 million yuan. At present, Nanxin Medical Inspection Laboratory has carried out intestinal and female reproductive tract microbial testing services, pathogenic microbial metagenomic testing services, vitamin metabolism testing and human immunity assessment and other clinical major health testing services, committed to making micro-ecologies benefit mankind Health; At the same time, Nanxin Laboratories also develops multi-omics scientific research and technical services serving major universities, hospitals, and research institutes. Genomics, transcriptomics, proteomics and metabolomics are jointly combined to promote the latest biomedical industry Scientific research results.
年度总收入
5000-10000万美元
前三市场
营业地点
Guangzhou,Guangdong Province,China(Mainland)
Total Employees
101-200人
成立年份
2015
注册资金
RMB 18160000
办公区
1000-3000平方米
產品認證
CE,ISO13485,CE
贸易能力
出口百分比
最近的港口
Huangpu Customs Port
接受的交付條款
FOB
雇员
101-200人
接受的付款貨幣
USD,CNY
接受的付款方式
Credit Card,PayPal,Cash
貿易署員工人數
平均提前期
5 天)
资质认证
  • 图片
  • Certification Name
  • 认证
  • 主营业务
  • 有效时间
CE
Other
产品证书/检测报告
2020-04-11 ~ 2025-04-11
ISO13485
China
管理体系证书
2020-03-27 ~ 2023-03-27
CE
Other
产品证书/检测报告
2020-04-11 ~ 2025-04-11
生产能力
工厂规模
1000-3000平方米
工厂位置
5/F Building A,No.83,Ruihe Road,Huangpu District,Guangzhou,China
合同起草(名词
提供OEM服务
年产值
1000万-5000万美元
品管人员数量
5-10人
研发人员人数
31-40人
联系我们
相关公司